COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,397 Articles (22,816 medRxiv, 8,581 bioRxiv)

Most recent first Previous |  Page 2289: Articles 22881-22890  | Next

COVID-19 transmission in a university setting: a rapid review of modelling studies
Christensen, H., Turner, K., Trickey, A., Booton, R. D., Hemani, G., Nixon, E., Relton, C., Danon, L., Hickman, M., Brooks Pollock, E.
10.1101/2020.09.07.20189688 — Posted: 2020-09-09
On the Role of Artificial Intelligence in Medical Imaging of COVID-19
Born, J., Beymer, D., Rajan, D., Coy, A., Mukherjee, V. V., Manica, M., Prasanna, P., Ballah, D., Shah, P. L., Karteris, E., Robertus, J. L., Gabrani, M., Rosen-Zvi, M.
10.1101/2020.09.02.20187096 — Posted: 2020-09-09
Structural characterization of Nonstructural protein 1 from SARS-CoV-2
Semper, C., Watanabe, N., Savchenko, A.
10.1101/2020.09.08.288191 — Posted: 2020-09-08
Many bat species are not potential hosts of SARS-CoV and SARS-CoV-2: Evidence from ACE2 receptor usage
Yan, H., Jiao, H., Liu, Q., Zhang, Z., Wang, X., Guo, M., Wang, B.-J., Lan, K., Chen, Y., Zhao, H.
10.1101/2020.09.08.284737 — Posted: 2020-09-08
Interaction of human ACE2 to membrane-bound SARS-CoV-1 and SARS-CoV-2 S glycoproteins
Anand, S. P., Chen, Y., Prevost, J., Gasser, R., Beaudoin-Bussieres, G., Abrams, C. F., Pazgier, M., Finzi, A.
10.1101/2020.09.07.286567 — Posted: 2020-09-08 Discussion: Onsite
In vitro study of BromAc on SARS-CoV-2 spike and envelope proteins shows synergy and disintegration at modest concentrations
Akhter, J., Pillai, K., Badar, S., Mekkawy, A., Valle, S., Morris, D. L.
10.1101/2020.09.07.286906 — Posted: 2020-09-08
Antibody binding to SARS-CoV-2 S glycoprotein correlates with, but does not predict neutralization
Ding, S., Laumaea, A., Gasser, R., Medjahed, H., Pancera, M., Stamatatos, L., McGuire, A., Bazin, R., Finzi, A.
10.1101/2020.09.08.287482 — Posted: 2020-09-08 Discussion: Offsite
A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates
Vogel, A., Kanevsky, I., Che, Y., Swanson, K., Muik, A., Vormehr, M., Kranz, L., Walzer, K., Hein, S., Gueler, A., Loschko, J., Maddur, M., Tompkins, K., Cole, J., Lui, B. G., Ziegenhals, T., Plaschke, A., Eisel, D., Dany, S., Fesser, S., Erbar, S., Bates, f., Schneider, D., Jesionek, B., Saenger, B., Wallisch, A.-K., Feuchter, Y., Junginger, H., Krumm, S., Heinen, A., Adams-Quack, P., Schlereth, J., Kroener, C., Hall-Ursone, S., Brasky, K., Griffor, M. C., Han, S., Lees, J., Mashalidis, E., Sahasrabudhe, P., Tan, C., Pavliakova, D., Singh, G., Fontes-Garfias, C., Pride, M., Scully, I., Ciolino, t., Obregon, J., Gazi, M., Carrion, R., Alfson, K., Kalina, W., Kaushal, D., Shi, P.-Y., Klamp, T., Rosenbaum, C., Kuhn, A., Tuereci, O., Dormitzer, P., Jansen, K., Sahin, U.
10.1101/2020.09.08.280818 — Posted: 2020-09-08 Discussion: Onsite
Analysis of SARS-CoV-2 genomes from across Africa reveals potentially clinically relevant mutations.
Iweriebor, B. C., Egbule, O. S., Danso, S. O., Akujuru, E., Ibubeleye, V. T., Oweredaba, C. I., Ogharanduku, T., Manu, A., Longjohn, M. N.
10.1101/2020.09.08.287201 — Posted: 2020-09-08
UVA radiation could be a significant contributor to sunlight inactivation of SARS-CoV-2
Luzzatto-Fegiz, P., Temprano-Coleto, F., Peaudecerf, F. J., Landel, J. R., Zhu, Y., McMurry, J. A.
10.1101/2020.09.07.286666 — Posted: 2020-09-08 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).